A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical

See also
Status	Clinical Trial	Phase
Completed	`NCT03276936` - A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea	Phase 3
Completed	`NCT02601963` - Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT02268474` - Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea	N/A
Completed	`NCT01555463` - Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea	Phase 3
Active, not recruiting	`NCT03667222` - Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea	Phase 2
Terminated	`NCT03564145` - A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea	Phase 3
Completed	`NCT05150587` - Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea	Phase 2
Completed	`NCT03263273` - Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT05343455` - A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)	Phase 3
Completed	`NCT01872715` - Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea	Phase 4
Completed	`NCT01784133` - A Twelve Week Safety and Efficacy Study in Rosacea	Phase 2
Completed	`NCT05296629` - A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.	Phase 3
Completed	`NCT05838170` - Study of TP-04 in Participants With Papulopustular Rosacea	Phase 2
Recruiting	`NCT06013371` - PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea	Phase 2
Recruiting	`NCT03864978` - Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test	Phase 2
Completed	`NCT03564119` - A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea	Phase 3
Completed	`NCT03079531` - Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea	Phase 1/Phase 2
Completed	`NCT01045551` - Open Label Pilot Study of Apremilast in Treatment of Rosacea	Phase 2
Completed	`NCT03448939` - A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea	Phase 3
Completed	`NCT05675501` - Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties	Phase 1

NCT number	NCT02393937
Study type	Interventional
Source	bioRASI, LLC
Contact
Status	Completed
Phase	Phase 3
Start date	February 2015
Completion date	October 2015

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms